ID   MAOM_HUMAN              Reviewed;         584 AA.
AC   P23368; B2R8J2; Q9BWL6; Q9BYG1; Q9H4B2;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 1.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=NAD-dependent malic enzyme, mitochondrial;
DE            Short=NAD-ME;
DE            EC=1.1.1.38;
DE   AltName: Full=Malic enzyme 2;
DE   Flags: Precursor;
GN   Name=ME2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1993674;
RA   Loeber G., Infante A.A., Maurer-Fogy I., Krystek E., Dworkin M.B.;
RT   "Human NAD(+)-dependent mitochondrial malic enzyme. cDNA cloning,
RT   primary structure, and expression in Escherichia coli.";
RL   J. Biol. Chem. 266:3016-3021(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 37-80.
RX   PubMed=11401430; DOI=10.1006/geno.2000.6454;
RA   Yanaihara N., Kohno T., Takakura S., Takei K., Otsuka A., Sunaga N.,
RA   Takahashi M., Yamazaki M., Tashiro H., Fukuzumi Y., Fujimori Y.,
RA   Hagiwara K., Tanaka T., Yokota J.;
RT   "Physical and transcriptional map of a 311-kb segment of chromosome
RT   18q21, a candidate lung tumor suppressor locus.";
RL   Genomics 72:169-179(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 421-584 (ISOFORM 1).
RC   TISSUE=B-cell;
RA   Abts H.;
RL   Thesis (1995), University of Cologne, Germany.
RN   [8]
RP   PROTEIN SEQUENCE OF 19-33.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-156; LYS-224; LYS-240;
RP   LYS-272 AND LYS-346, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   PubMed=10467136; DOI=10.1016/S0969-2126(99)80115-4;
RA   Xu Y., Bhargava G., Wu H., Loeber G., Tong L.;
RT   "Crystal structure of human mitochondrial NAD(P)(+)-dependent malic
RT   enzyme: a new class of oxidative decarboxylases.";
RL   Structure 7:877-889(1999).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 21-584 IN COMPLEX WITH NAD;
RP   DIVALENT METAL ION AND SUBSTRATE ANALOG, AND HOMOTETRAMERIZATION.
RX   PubMed=10700286; DOI=10.1038/73378;
RA   Yang Z., Floyd D.L., Loeber G., Tong L.;
RT   "Structure of a closed form of human malic enzyme and implications for
RT   catalytic mechanism.";
RL   Nat. Struct. Biol. 7:251-257(2000).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 20-573 IN COMPLEX WITH ATP;
RP   MANGANESE; ALLOSTERIC ACTIVATOR AND SUBSTRATE ANALOG, MUTAGENESIS OF
RP   ARG-67 AND ARG-91, AND HOMOTETRAMERIZATION.
RX   PubMed=12121650; DOI=10.1016/S0969-2126(02)00788-8;
RA   Yang Z., Lanks C.W., Tong L.;
RT   "Molecular mechanism for the regulation of human mitochondrial
RT   NAD(P)+-dependent malic enzyme by ATP and fumarate.";
RL   Structure 10:951-960(2002).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 21-584 IN COMPLEX WITH
RP   SUBSTRATE; NAD; MANGANESE AND ALLOSTERIC ACTIVATOR, AND ENZYME
RP   MECHANISM.
RX   PubMed=12962632; DOI=10.1016/S0969-2126(03)00168-0;
RA   Tao X., Yang Z., Tong L.;
RT   "Crystal structures of substrate complexes of malic enzyme and
RT   insights into the catalytic mechanism.";
RL   Structure 11:1141-1150(2003).
CC   -!- CATALYTIC ACTIVITY: (S)-malate + NAD(+) = pyruvate + CO(2) + NADH.
CC   -!- CATALYTIC ACTIVITY: Oxaloacetate = pyruvate + CO(2).
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Note=Divalent metal cations. Prefers magnesium or manganese.;
CC   -!- ENZYME REGULATION: Subject to allosteric activation by fumarate.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:10700286,
CC       ECO:0000269|PubMed:12121650, ECO:0000269|PubMed:12962632}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P23368-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23368-2; Sequence=VSP_042717;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: This isoenzyme can also use NADP(+) but is more
CC       effective with NAD(+).
CC   -!- SIMILARITY: Belongs to the malic enzymes family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M55905; AAA36197.1; -; mRNA.
DR   EMBL; AB045122; BAB40980.1; -; Genomic_DNA.
DR   EMBL; AK313391; BAG36189.1; -; mRNA.
DR   EMBL; AC015864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087687; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471096; EAW62980.1; -; Genomic_DNA.
DR   EMBL; BC000147; AAH00147.1; -; mRNA.
DR   EMBL; AJ294818; CAC14574.1; -; mRNA.
DR   CCDS; CCDS11948.1; -. [P23368-1]
DR   CCDS; CCDS54187.1; -. [P23368-2]
DR   PIR; A39503; A39503.
DR   RefSeq; NP_001161807.1; NM_001168335.1. [P23368-2]
DR   RefSeq; NP_002387.1; NM_002396.4. [P23368-1]
DR   UniGene; Hs.233119; -.
DR   PDB; 1DO8; X-ray; 2.20 A; A/B/C/D=21-584.
DR   PDB; 1EFK; X-ray; 2.60 A; A/B/C/D=1-584.
DR   PDB; 1EFL; X-ray; 2.60 A; A/B/C/D=1-584.
DR   PDB; 1GZ3; X-ray; 2.30 A; A/B/C/D=20-573.
DR   PDB; 1GZ4; X-ray; 2.20 A; A/B/C/D=23-573.
DR   PDB; 1PJ2; X-ray; 2.30 A; A/B/C/D=21-584.
DR   PDB; 1PJ3; X-ray; 2.10 A; A/B/C/D=21-584.
DR   PDB; 1PJ4; X-ray; 2.30 A; A/B/C/D=21-584.
DR   PDB; 1PJL; X-ray; 2.90 A; A/B/C/D/E/F/G/H=1-584.
DR   PDB; 1QR6; X-ray; 2.10 A; A/B=1-584.
DR   PDBsum; 1DO8; -.
DR   PDBsum; 1EFK; -.
DR   PDBsum; 1EFL; -.
DR   PDBsum; 1GZ3; -.
DR   PDBsum; 1GZ4; -.
DR   PDBsum; 1PJ2; -.
DR   PDBsum; 1PJ3; -.
DR   PDBsum; 1PJ4; -.
DR   PDBsum; 1PJL; -.
DR   PDBsum; 1QR6; -.
DR   ProteinModelPortal; P23368; -.
DR   SMR; P23368; -.
DR   BioGrid; 110364; 5.
DR   IntAct; P23368; 2.
DR   MINT; MINT-4530114; -.
DR   STRING; 9606.ENSP00000321070; -.
DR   DrugBank; DB03589; Alpha-Ketomalonic Acid.
DR   DrugBank; DB01677; Fumarate.
DR   DrugBank; DB03499; Malate Ion.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB03680; Tartronate.
DR   iPTMnet; P23368; -.
DR   PhosphoSitePlus; P23368; -.
DR   SwissPalm; P23368; -.
DR   BioMuta; ME2; -.
DR   DMDM; 126733; -.
DR   EPD; P23368; -.
DR   MaxQB; P23368; -.
DR   PaxDb; P23368; -.
DR   PeptideAtlas; P23368; -.
DR   PRIDE; P23368; -.
DR   DNASU; 4200; -.
DR   Ensembl; ENST00000321341; ENSP00000321070; ENSG00000082212. [P23368-1]
DR   Ensembl; ENST00000382927; ENSP00000372384; ENSG00000082212. [P23368-2]
DR   GeneID; 4200; -.
DR   KEGG; hsa:4200; -.
DR   UCSC; uc002ley.4; human. [P23368-1]
DR   CTD; 4200; -.
DR   DisGeNET; 4200; -.
DR   GeneCards; ME2; -.
DR   HGNC; HGNC:6984; ME2.
DR   HPA; HPA008247; -.
DR   HPA; HPA008880; -.
DR   MIM; 154270; gene.
DR   neXtProt; NX_P23368; -.
DR   OpenTargets; ENSG00000082212; -.
DR   PharmGKB; PA30724; -.
DR   eggNOG; KOG1257; Eukaryota.
DR   eggNOG; COG0281; LUCA.
DR   GeneTree; ENSGT00390000000754; -.
DR   HOGENOM; HOG000042486; -.
DR   HOVERGEN; HBG000746; -.
DR   InParanoid; P23368; -.
DR   KO; K00027; -.
DR   OMA; EPFTHSA; -.
DR   OrthoDB; EOG091G04H9; -.
DR   PhylomeDB; P23368; -.
DR   TreeFam; TF300537; -.
DR   BRENDA; 1.1.1.38; 2681.
DR   SABIO-RK; P23368; -.
DR   EvolutionaryTrace; P23368; -.
DR   GeneWiki; ME2; -.
DR   GeneWiki; ME2_(gene); -.
DR   GenomeRNAi; 4200; -.
DR   PRO; PR:P23368; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000082212; -.
DR   CleanEx; HS_ME2; -.
DR   Genevisible; P23368; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0004471; F:malate dehydrogenase (decarboxylating) (NAD+) activity; TAS:ProtInc.
DR   GO; GO:0004473; F:malate dehydrogenase (decarboxylating) (NADP+) activity; IBA:GO_Central.
DR   GO; GO:0004470; F:malic enzyme activity; IMP:CACAO.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0008948; F:oxaloacetate decarboxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006108; P:malate metabolic process; IBA:GO_Central.
DR   GO; GO:0006090; P:pyruvate metabolic process; IBA:GO_Central.
DR   GO; GO:1902031; P:regulation of NADP metabolic process; IMP:CACAO.
DR   Gene3D; 3.40.50.10380; -; 1.
DR   InterPro; IPR015884; Malic_enzyme_CS.
DR   InterPro; IPR012301; Malic_N_dom.
DR   InterPro; IPR012302; Malic_NAD-bd.
DR   InterPro; IPR001891; Malic_OxRdtase.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF00390; malic; 1.
DR   Pfam; PF03949; Malic_M; 1.
DR   PIRSF; PIRSF000106; ME; 1.
DR   PRINTS; PR00072; MALOXRDTASE.
DR   SMART; SM01274; malic; 1.
DR   SMART; SM00919; Malic_M; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00331; MALIC_ENZYMES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Alternative splicing;
KW   Complete proteome; Direct protein sequencing; Metal-binding;
KW   Mitochondrion; NAD; Oxidoreductase; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     18       Mitochondrion.
FT                                {ECO:0000269|PubMed:12665801}.
FT   CHAIN        19    584       NAD-dependent malic enzyme,
FT                                mitochondrial.
FT                                /FTId=PRO_0000018537.
FT   NP_BIND     165    173       NAD. {ECO:0000269|PubMed:10700286,
FT                                ECO:0000269|PubMed:12962632}.
FT   NP_BIND     311    328       NAD. {ECO:0000269|PubMed:10700286,
FT                                ECO:0000269|PubMed:12962632}.
FT   ACT_SITE    112    112       Proton donor.
FT   ACT_SITE    183    183       Proton acceptor.
FT   METAL       255    255       Divalent metal cation.
FT   METAL       256    256       Divalent metal cation.
FT   METAL       279    279       Divalent metal cation.
FT   BINDING      67     67       Allosteric activator.
FT                                {ECO:0000269|PubMed:12121650,
FT                                ECO:0000269|PubMed:12962632}.
FT   BINDING      91     91       Allosteric activator.
FT                                {ECO:0000269|PubMed:12121650,
FT                                ECO:0000269|PubMed:12962632}.
FT   BINDING     165    165       Substrate. {ECO:0000269|PubMed:12962632}.
FT   BINDING     259    259       NAD. {ECO:0000269|PubMed:10700286,
FT                                ECO:0000269|PubMed:12962632}.
FT   BINDING     421    421       Substrate. {ECO:0000269|PubMed:12962632}.
FT   BINDING     466    466       Substrate. {ECO:0000269|PubMed:12962632}.
FT   SITE        279    279       Important for activity. {ECO:0000250}.
FT   MOD_RES     156    156       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     224    224       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     240    240       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     272    272       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     346    346       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     474    584       VALAVILCNTRHISDSVFLEAAKALTSQLTDEELAQGRLYP
FT                                PLANIQEVSINIAIKVTEYLYANKMAFRYPEPEDKAKYVKE
FT                                RTWRSEYDSLLPDVYEWPESASSPPVITE -> YRIPIC
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042717.
FT   VARIANT     114    114       P -> L (in dbSNP:rs16952692).
FT                                /FTId=VAR_034104.
FT   VARIANT     450    450       G -> E (in dbSNP:rs649224).
FT                                /FTId=VAR_050017.
FT   MUTAGEN      67     67       R->S: Abolishes activation by fumarate.
FT                                {ECO:0000269|PubMed:12121650}.
FT   MUTAGEN      91     91       R->T: Abolishes activation by fumarate.
FT                                {ECO:0000269|PubMed:12121650}.
FT   CONFLICT    263    263       F -> Y (in Ref. 3; BAG36189).
FT                                {ECO:0000305}.
FT   HELIX        27     30       {ECO:0000244|PDB:1PJ3}.
FT   TURN         32     34       {ECO:0000244|PDB:1PJ3}.
FT   HELIX        37     39       {ECO:0000244|PDB:1PJ3}.
FT   HELIX        42     47       {ECO:0000244|PDB:1PJ3}.
FT   TURN         51     53       {ECO:0000244|PDB:1PJ3}.
FT   HELIX        61     74       {ECO:0000244|PDB:1PJ3}.
FT   HELIX        78     89       {ECO:0000244|PDB:1PJ3}.
FT   HELIX        93    102       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       104    111       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       115    121       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       123    126       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      132    136       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       137    139       {ECO:0000244|PDB:1PJ3}.
FT   TURN        140    142       {ECO:0000244|PDB:1PJL}.
FT   HELIX       143    147       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      157    161       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      163    165       {ECO:0000244|PDB:1PJ3}.
FT   TURN        167    169       {ECO:0000244|PDB:1QR6}.
FT   HELIX       173    177       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       178    191       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       195    197       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      198    205       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       212    214       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       229    246       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      251    254       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       259    269       {ECO:0000244|PDB:1PJ3}.
FT   TURN        270    272       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      273    277       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       278    298       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       302    304       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      307    310       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       314    329       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       334    339       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      341    345       {ECO:0000244|PDB:1PJ3}.
FT   TURN        360    362       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       363    365       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       377    384       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      387    391       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      394    396       {ECO:0000244|PDB:1GZ3}.
FT   HELIX       401    410       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      415    418       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       423    425       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      426    428       {ECO:0000244|PDB:1QR6}.
FT   HELIX       430    436       {ECO:0000244|PDB:1PJ3}.
FT   TURN        437    439       {ECO:0000244|PDB:1PJ3}.
FT   STRAND      442    447       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       467    469       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       471    480       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       488    499       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       504    508       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       516    518       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       519    536       {ECO:0000244|PDB:1PJ3}.
FT   HELIX       549    555       {ECO:0000244|PDB:1PJ3}.
SQ   SEQUENCE   584 AA;  65444 MW;  4CEF9AF89B07D93D CRC64;
     MLSRLRVVST TCTLACRHLH IKEKGKPLML NPRTNKGMAF TLQERQMLGL QGLLPPKIET
     QDIQALRFHR NLKKMTSPLE KYIYIMGIQE RNEKLFYRIL QDDIESLMPI VYTPTVGLAC
     SQYGHIFRRP KGLFISISDR GHVRSIVDNW PENHVKAVVV TDGERILGLG DLGVYGMGIP
     VGKLCLYTAC AGIRPDRCLP VCIDVGTDNI ALLKDPFYMG LYQKRDRTQQ YDDLIDEFMK
     AITDRYGRNT LIQFEDFGNH NAFRFLRKYR EKYCTFNDDI QGTAAVALAG LLAAQKVISK
     PISEHKILFL GAGEAALGIA NLIVMSMVEN GLSEQEAQKK IWMFDKYGLL VKGRKAKIDS
     YQEPFTHSAP ESIPDTFEDA VNILKPSTII GVAGAGRLFT PDVIRAMASI NERPVIFALS
     NPTAQAECTA EEAYTLTEGR CLFASGSPFG PVKLTDGRVF TPGQGNNVYI FPGVALAVIL
     CNTRHISDSV FLEAAKALTS QLTDEELAQG RLYPPLANIQ EVSINIAIKV TEYLYANKMA
     FRYPEPEDKA KYVKERTWRS EYDSLLPDVY EWPESASSPP VITE
//
